Roche Develops New Diagnostic Test to Detect and Differentiate BA.2.75 from BA.4 and BA.5 Subvariants

Gelonghui August 22nd丨Swiss pharmaceutical company Roche (RHHBY.US) stated that it has developed a COVID-19 testing method for researchers, which can detect the latest subvariant BA.2.75 and distinguish it from BA.4 or BA.5.